Sakon M, Monden M, Gotoh M, Kanai T, Umeshita K, Nakano Y, Mori T, Sakurai M, Wakasa K
Second Department of Surgery, Osaka University Hospital, Japan.
Am J Surg. 1992 Feb;163(2):251-6. doi: 10.1016/0002-9610(92)90111-4.
The relationship between pathologic prognostic factors and abnormal levels of des-gamma-carboxy prothrombin and alpha-fetoprotein was investigated in 42 patients with resectable hepatocellular carcinoma. The frequencies of macroscopic massive type, intrahepatic metastasis, and portal vein tumor thrombus were significantly higher in patients with positive des-gamma-carboxy prothrombin (p less than 0.05) but not with alpha-fetoprotein. Other histologic factors in tumorous and nontumorous tissues were not significantly different irrespective of the positivity of these markers. In patients with tumors not more than 6 cm in diameter, the frequency of intrahepatic metastasis was positively correlated with the positivity of des-gamma-carboxy prothrombin (p less than 0.05) and inversely with that of alpha-fetoprotein (p less than 0.05). Furthermore, intrahepatic metastasis was most frequently observed in patients with positive des-gamma-carboxy prothrombin and negative alpha-fetoprotein (eight of nine) and least frequently in cases with negative des-gamma-carboxy prothrombin and positive alpha-fetoprotein (one of eight). These findings indicated that both des-gamma-carboxy prothrombin and alpha-fetoprotein might be useful markers for the prediction of intrahepatic spread of hepatocellular carcinoma.
对42例可切除肝细胞癌患者研究了病理预后因素与去γ-羧基凝血酶原及甲胎蛋白异常水平之间的关系。去γ-羧基凝血酶原阳性患者中,巨块型、肝内转移及门静脉瘤栓的发生率显著更高(p<0.05),而甲胎蛋白阳性患者则不然。无论这些标志物是否阳性,肿瘤组织和非肿瘤组织中的其他组织学因素均无显著差异。在直径不超过6cm的肿瘤患者中,肝内转移发生率与去γ-羧基凝血酶原阳性呈正相关(p<0.05),与甲胎蛋白阳性呈负相关(p<0.05)。此外,去γ-羧基凝血酶原阳性且甲胎蛋白阴性的患者中肝内转移最常见(9例中有8例),而去γ-羧基凝血酶原阴性且甲胎蛋白阳性的患者中肝内转移最少见(8例中有1例)。这些结果表明,去γ-羧基凝血酶原和甲胎蛋白可能都是预测肝细胞癌肝内播散的有用标志物。